Place of magnesium drugs in pregnant women with cardiovascular disease

By now there is a substantial evidence on the role of magnesium deficiency, which can occur during pregnancy even in healthy women in case of its insufficient intake through food, in the deterioration of the clinical condition and obstetric complications, especially in patients with cardiovascular d...

Full description

Bibliographic Details
Main Author: R. I. Stryuk
Format: Article
Language:Russian
Published: Remedium Group LLC 2015-12-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/253
_version_ 1797841401508003840
author R. I. Stryuk
author_facet R. I. Stryuk
author_sort R. I. Stryuk
collection DOAJ
description By now there is a substantial evidence on the role of magnesium deficiency, which can occur during pregnancy even in healthy women in case of its insufficient intake through food, in the deterioration of the clinical condition and obstetric complications, especially in patients with cardiovascular disease. Therefore, complex preventive therapy which apart from treatment of hypertension and autonomic dysfunction with mitral valve prolapse, includes oral organic magnesium formulations (lactate, citrate, pidolate) in combination with pyridoxine to replenish magnesium deficiency in these patients has a pronounced positive effect both on the mother, the fetus, and the course of pregnancy.
first_indexed 2024-04-09T16:30:16Z
format Article
id doaj.art-f61f9e1ff364417297a91fe456590c5d
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:30:16Z
publishDate 2015-12-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-f61f9e1ff364417297a91fe456590c5d2023-04-23T06:57:09ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902015-12-010910010510.21518/2079-701X-2015-9-100-105253Place of magnesium drugs in pregnant women with cardiovascular diseaseR. I. Stryuk0Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Russia’s Ministry of HealthBy now there is a substantial evidence on the role of magnesium deficiency, which can occur during pregnancy even in healthy women in case of its insufficient intake through food, in the deterioration of the clinical condition and obstetric complications, especially in patients with cardiovascular disease. Therefore, complex preventive therapy which apart from treatment of hypertension and autonomic dysfunction with mitral valve prolapse, includes oral organic magnesium formulations (lactate, citrate, pidolate) in combination with pyridoxine to replenish magnesium deficiency in these patients has a pronounced positive effect both on the mother, the fetus, and the course of pregnancy.https://www.med-sovet.pro/jour/article/view/253беременностькардиоваскулярные заболеваниямагниевый дефицитпрепараты магнияpregnancycardiovascular diseasesmagnesium deficiencymagnesium preparations
spellingShingle R. I. Stryuk
Place of magnesium drugs in pregnant women with cardiovascular disease
Медицинский совет
беременность
кардиоваскулярные заболевания
магниевый дефицит
препараты магния
pregnancy
cardiovascular diseases
magnesium deficiency
magnesium preparations
title Place of magnesium drugs in pregnant women with cardiovascular disease
title_full Place of magnesium drugs in pregnant women with cardiovascular disease
title_fullStr Place of magnesium drugs in pregnant women with cardiovascular disease
title_full_unstemmed Place of magnesium drugs in pregnant women with cardiovascular disease
title_short Place of magnesium drugs in pregnant women with cardiovascular disease
title_sort place of magnesium drugs in pregnant women with cardiovascular disease
topic беременность
кардиоваскулярные заболевания
магниевый дефицит
препараты магния
pregnancy
cardiovascular diseases
magnesium deficiency
magnesium preparations
url https://www.med-sovet.pro/jour/article/view/253
work_keys_str_mv AT ristryuk placeofmagnesiumdrugsinpregnantwomenwithcardiovasculardisease